CONMED
CNMD
280 hedge funds and large institutions have $3.24B invested in CONMED in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 108 increasing their positions, 93 reducing their positions, and 39 closing their positions.
16% more repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 93
10% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 39
4.89% more ownership
Funds ownership: 109.71% → 114.6% (+4.9%)
0% less funds holding
Funds holding: 281 → 280 (-1)
31% less capital invested
Capital invested by funds: $4.69B → $3.24B (-$1.45B)
61% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $3.02M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$51.4M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$47M |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$24.6M |
| 4 |
EARNEST Partners
Atlanta,
Georgia
|
+$22.5M |
| 5 |
JG
Jefferies Group
New York
|
+$21.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$41.4M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$32.8M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$14M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$11.9M |
| 5 |
WI
Wafra Inc
New York
|
-$11.3M |
CNMD Hedge Fund Activity: Q2 2022 in Review
280 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2022, worth a combined $3.24B — down 31% from $4.69B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CNMD positions and 39 closed out — a net gain of 4 holders — while 108 added to existing stakes and 93 trimmed.
The largest buyer was Bank of America, adding an estimated $51.4M. The largest seller was Hood River Capital Management, exiting entirely with an estimated $41.4M sold.
- 280 institutional investors held CONMED (CNMD) as of Q2 2022, down from 281 in Q1 2022.
- Funds reported $3.24B of CONMED stock for Q2 2022, down 31% quarter-over-quarter.
- 43 funds opened new CONMED positions in Q2 2022 and 39 closed out, a net change of +4 holders.
- The largest CONMED buyer in Q2 2022 was Bank of America, an estimated $51.4M added.
- The largest CONMED seller in Q2 2022 was Hood River Capital Management, an estimated $41.4M sold.
Based on aggregated 13F filings for Q2 2022.